Cryoablation as Treatment for Renal Cell Carcinoma Induced Hematuria: A Case Report
American Journal of Interventional Radiology · 2018
DOI: 10.25259/ajir-36-2018 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Interventional Radiology, 2018. Verfasst von Shima Tafreshi und 3 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. Cryoablation therapy, which uses rapid freeze and thaw cycles to destroy diseased tissue, is the standard nephron-sparing option for RCC treatment. This case report suggests cryoablation as an effective therapy for hematuria in RCC. A 52-year-old male patient with Stage IV RCC presented to the ED with hematuria and flank pain. He was catheterized, and several blood clots were removed from the bladder. Embolization was considered, however renal angiography failed to demonstrate a tumoral blush and no target for embolization was identified. In lieu of continued large volume hematuria, cryoablation of the tumor was offered as a potential therapy. We describe a case of successful treatment of clinically significant hematuria in a patient with RCC with cryoablation.
Zitieren
APA
Tafreshi, S., Chengazi, H., Virdee, S., & Cantos, A. (2018). Cryoablation as Treatment for Renal Cell Carcinoma Induced Hematuria: A Case Report. American Journal of Interventional Radiology. https://doi.org/10.25259/ajir-36-2018
Vancouver
Tafreshi S, Chengazi H, Virdee S, Cantos A. Cryoablation as Treatment for Renal Cell Carcinoma Induced Hematuria: A Case Report. American Journal of Interventional Radiology. 2018. doi:10.25259/ajir-36-2018
BibTeX
@article{Tafreshi2018,
author = {Tafreshi, Shima and Chengazi, Harris and Virdee, Sanjiv and Cantos, Andrew},
title = {Cryoablation as Treatment for Renal Cell Carcinoma Induced Hematuria: A Case Report},
journal = {American Journal of Interventional Radiology},
year = {2018},
doi = {10.25259/ajir-36-2018}
}
EUVIMED